Oferta szkoleniowa GUMed
Wykład prof. THIERRY SOUSSI "Epidemiology of human cancer; Oncogene and Tumor suppressor gene; Colorectal cancer: a model for multistep carcinogenesis” w ramach projektu POWER.03.05.00-22-Z082/18 „Wielomodułowy program poprawy efektywności i jakości funkcjonowania Gdańskiego Uniwersytetu Medycznego”, zadanie 2 – Włączenie wykładowców zagranicznych w proces kształcenia (moduł 1) [2023-4678-304] [DANE ARCHIWALNE]
Termin: 08.12.2023Organizator: Katedra i Zakład Biochemii, GUMed
Kontakt: inf. o wyk dr hab. Beata Schlichtholz tel. 14 60 , zapisy Magdalena Perzanowska tel.1218
ul. Dębowa 30, 80-204 Gdańsk
tel.: 58 349 1460, fax: 58 349 1218, e-mail: kadrydydaktyka@gumed.edu.pl
Program kursu
Dzień | Temat wykładu lub innych zajęć |
---|---|
08.12.2023 08:00 | Professor Thierry Soussi is a team leader at the Centre de Recherche Saint-Antoine Team « Hematopoietic and Leukemic Development » UMRS_938, Sorbonne Université in Paris. He is a renowned scientist known for his work on the p53 protein and its role in cancer. Thierry Soussi has authored over 276 published articles and two patents. Since 1983, he teaches the molecular biology and genetics at the University P.M. Curie (name change to Sorbonne University in 2019), he was also giving lectures to MD students on molecular oncology at various universities in France. Awarded many prizes including The J. S. Bourdain prize from the Ligue contre le Cancer in 1991, Award from the French National Cancer Foundation in 1992, Scientist of the Year by the journal "Abstract Medecine" 1996, The J. Vallade Prize from the Fondation de France in 1997, Award "Paris" Ligue contre le Cancer in 1999 and Award « Chancellerie des Université » in 2000. He is a communicating editor for Human Mutation (Willey press, ), member of the editorial board for Trend in Molecular Medicine (Cell press), and member of the Advisory Committee of the center for personal medicine in Hadassah Medical Center, Jerusalem. Professor Thierry Soussi's work has significantly contributed to the understanding of the p53 protein, its role in cancer, and the development of tools for accurate variant annotations and interpretation of TP53 sequencing data. |